Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1978 1
1979 1
1980 5
1981 6
1982 5
1983 2
1984 6
1985 7
1986 2
1987 6
1988 6
1989 3
1990 5
1991 1
1992 4
1994 3
1995 3
1996 4
1997 2
1998 6
1999 8
2000 2
2001 9
2002 7
2003 8
2004 15
2005 18
2006 17
2007 30
2008 24
2009 31
2010 39
2011 59
2012 46
2013 76
2014 79
2015 74
2016 92
2017 91
2018 117
2019 130
2020 137
2021 175
2022 209
2023 189
2024 71

Text availability

Article attribute

Article type

Publication date

Search Results

1,623 results

Results by year

Filters applied: . Clear all
Page 1
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Dvorkin M, Shi J, Pan Z, Shi J, Wang X, Bai Y, Melkadze T, Pan Y, Min X, Viguro M, Li X, Zhao Y, Yang J, Makharadze T, Arkania E, Kang W, Wang Q, Zhu J; ASTRUM-005 Study Group. Cheng Y, et al. Among authors: wen g. JAMA. 2022 Sep 27;328(12):1223-1232. doi: 10.1001/jama.2022.16464. JAMA. 2022. PMID: 36166026 Free PMC article. Clinical Trial.
O-GlcNAcylation in cancer development and immunotherapy.
He XF, Hu X, Wen GJ, Wang Z, Lin WJ. He XF, et al. Among authors: wen gj. Cancer Lett. 2023 Jul 10;566:216258. doi: 10.1016/j.canlet.2023.216258. Epub 2023 Jun 4. Cancer Lett. 2023. PMID: 37279852 Review.
Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma.
Yang X, Wang H, Zhang L, Yao S, Dai J, Wen G, An J, Jin H, Du Q, Hu Y, Zheng L, Chen X, Yi Z, Tuo B. Yang X, et al. Among authors: wen g. Biomed Pharmacother. 2023 Jul;163:114792. doi: 10.1016/j.biopha.2023.114792. Epub 2023 Apr 28. Biomed Pharmacother. 2023. PMID: 37121148 Free article. Review.
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C.
Zhu P, Li SY, Ding J, Fei Z, Sun SN, Zheng ZH, Wei D, Jiang J, Miao JL, Li SZ, Luo X, Zhang K, Wang B, Zhang K, Pu S, Wang QT, Zhang XY, Wen GL, Liu JO, August JT, Bian H, Chen ZN, He YW. Zhu P, et al. Among authors: wen gl. J Pharm Anal. 2023 Jun;13(6):616-624. doi: 10.1016/j.jpha.2023.04.012. Epub 2023 Apr 21. J Pharm Anal. 2023. PMID: 37440907 Free PMC article.
Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy.
Yue X, Liu T, Wang X, Wu W, Wen G, Yi Y, Wu J, Wang Z, Zhan W, Wu R, Meng Y, Cao Z, Le L, Qiu W, Zhang X, Li Z, Chen Y, Wan G, Bu X, Peng Z, Liu RY. Yue X, et al. Among authors: wen g. Acta Pharm Sin B. 2023 Aug;13(8):3382-3399. doi: 10.1016/j.apsb.2023.05.017. Epub 2023 May 19. Acta Pharm Sin B. 2023. PMID: 37655321 Free PMC article.
APOBEC3B: Future direction of liver cancer research.
Yang X, Dai J, Yao S, An J, Wen G, Jin H, Zhang L, Zheng L, Chen X, Yi Z, Tuo B. Yang X, et al. Among authors: wen g. Front Oncol. 2022 Sep 20;12:996115. doi: 10.3389/fonc.2022.996115. eCollection 2022. Front Oncol. 2022. PMID: 36203448 Free PMC article. Review.
1,623 results